BioSpace News Archive

The antibody is still being evaluated in clinical studies, with a large-scale Phase III trial expected to wrap in the second half of 2022.

Total payment amounts are contingent on the number of governments that will agree to suspend their lawsuits as part of the deal.

The life sciences is always a frenetic sector when it comes to mergers & acquisitions, initial public offerings (IPOs) and Series A announcements (not to mention B and C rounds). But during the second quarter of 2021, these companies were especially busy bees – all positive signs that the industry is still booming coming out of the COVID-19 pandemic.

Companies such as Indoor Biotechnologies in Virginia are leveraging cutting-edge scientific techniques to knock out the Fel d 1 protein completely from the cats.

For the past year, Abbott Laboratories and Quest Diagnostics saw their revenue driven by COVID-19 diagnostics, but that seems to be changing as more and more vaccinated individuals are seeking medical advice for non-viral related issues.

WHO Investigators have attempted to return to the Wuhan lab to find the origins of the novel coronavirus but are now being blocked by the Chinese government.

Biotech company Slingshot Biosciences announced Thursday it had closed a $23 million Series A financing round led by Northpond Ventures.

Shoulder replacement is a surgical procedure that replaces the original ball and socket surfaces of the shoulder with similar shaped prosthetic implants.

Healthcare sector is improving at a massive rate. The industry is inculcating new technologies that can redefine the medical business from its core.

Nose is a vital organ, which plays a significant role in respiration and facial appearance. The prominent and central position of the nose, makes it susceptible to injuries, deformities, and fractures.